Company intelligence / Profile preview

Neurocast

Amsterdam, Netherlands
Ownership
Private
Development stage
Other
01

Overview

Neurocast has completed FDA device registration and its platform is used in European clinics to monitor cognitive and motor function in neurological disease, with validation in clinical trials and a 600-patient trial for MS in the Netherlands[2][3][4].

Therapeutic areas
NeurologyPsychiatry
Modalities
DeviceDigital biomarkerNon-pharmacological therapy
Industry
Physiological Monitoring
02

Partnerships

JLabs (Johnson & Johnson Innovation)Pharma clinical trials partnersAcademic clinical research partners

Beyond the preview

Go deeper on Neurocast.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from trial design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Licensing & deals

Full profile access

Explore licensing agreements, acquisitions, and the assets behind each deal.

  • Partners
  • Deal terms
  • Milestones

Funding history

Full profile access

Trace financing activity and the investors behind a company’s development.

  • Funding rounds
  • Investors
  • Capital raised

Competitive landscape

Full profile access

Compare peer pipelines by target, modality, and therapeutic area.

  • Peer companies
  • Targets
  • Pipeline overlap

Technologies & patents

Full profile access

Explore technology platforms and the patent landscape around relevant assets.

  • Platforms
  • Patents
  • Assignees

Research & analysis

Full profile access

Connect company news and source material to the questions you’re investigating.

  • Company news
  • Sources
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Neurocast.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call